CORRELATION OF CA 15.3 LEVELS WITH METASTASIS IN BREAST CANCER

Authors

  • KARTHIKHAEYAN TR Department of General Surgery, KMCH IHSR, Coimbatore, Tamil Nadu, India https://orcid.org/0000-0003-1953-3117
  • ASWIN KARTHIK PERIASAMY Department of Neuro Surgery, GMKMCH, Salem, Tamil Nadu, India
  • ANKITKUMAR SHARMA Department of Urology, Manipal Hospitals, Whitefield, Bengaluru, Karnataka, India.

DOI:

https://doi.org/10.22159/ajpcr.2023v16i9.49016

Keywords:

Breast Cancer, Tumour Markers, Cancer, Diagnosis, Metastasis, Cancer Antigen CA15.3

Abstract

 Objectives: The objective is to measure the serum levels of Cancer Antigen CA 15.3 in breast cancer patients with metastasis and without metastasis and compare the mean values between them. The study investigated the correlation between CA 15.3 levels and metastasis in breast cancer.

Methods: The study was conducted with 45 female patients in a tertiary care center in India, and metastatic evaluation was done using positron emission tomography–computed tomography.

Results: The results indicated that CA 15.3 levels were significantly higher in the metastatic group compared to the non-metastatic group.

Conclusion: CA 15.3 has the potential as a diagnostic tool for early detection of metastases in breast cancer patients.

Downloads

Download data is not yet available.

References

Schwartz S, Brunicardi F. Schwartz’s Principles of Surgery. New York: McGraw-Hill Medical; 2010.

Duffy MJ, Shering S, Sherry F, McDermott E, O’Higgins N. CA 15-3: A prognostic marker in breast cancer. Int J Biol Markers 2000;15:330-3. doi: 10.1177/172460080001500410, PMID 11192829

Shao Y, Sun X, He Y, Liu C, Liu H. Elevated levels of serum tumor markers CEA and CA153 are prognostic parameters for different molecular subtypes of breast cancer. PLoS One 2015;10:e0133830.

Shering SG, Sherry F, McDermott EW, O’Higgins NJ, Duffy MJ. Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinoma. Cancer 1998;83:2521-7. doi: 10.1002/(SICI)1097- 0142(19981215)83:12<2521:AID-CNCR17>3.0.CO;2-A, PMID 9874458

Moazzezy N, Farahany TZ, Oloomi M, Bouzari S. Relationship between preoperative serum CA15-3 and CEA levels and clinicopathological parameters in breast cancer. Asian Pac J Cancer Prev 2014;15:1685-8. doi: 10.7314/apjcp.2014.15.4.1685, PMID 24641390

Gonssaud B, Goussot V, Berriolo-Riedinger A, Saïtta-Aribau E, Coutant C, Cochet A, et al. Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer. Ann Biol Clin (Paris) 2017;75:421-9. doi: 10.1684/abc.2017.1257, PMID 28751287

Published

07-09-2023

How to Cite

KARTHIKHAEYAN TR, ASWIN KARTHIK PERIASAMY, and ANKITKUMAR SHARMA. “CORRELATION OF CA 15.3 LEVELS WITH METASTASIS IN BREAST CANCER”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 9, Sept. 2023, pp. 42-44, doi:10.22159/ajpcr.2023v16i9.49016.

Issue

Vol 16 Issue 9 September 2023

Section

Original Article(s)

Copyright (c) 2023 Karthikhaeyan TR, Aswin Karthik, Ankit Kumar

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.

Crossref
Scopus
Google Scholar
Europe PMC